IRIS
SCUTERI, Damiana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.152
EU - Europa 1.250
AS - Asia 222
AF - Africa 164
SA - Sud America 14
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.104
IT - Italia 507
UA - Ucraina 224
SN - Senegal 164
DE - Germania 162
AT - Austria 91
CN - Cina 79
SE - Svezia 77
IE - Irlanda 63
HK - Hong Kong 60
CA - Canada 42
FR - Francia 35
IN - India 24
FI - Finlandia 23
GB - Regno Unito 18
JP - Giappone 18
BE - Belgio 13
TR - Turchia 13
BR - Brasile 11
AU - Australia 9
KR - Corea 7
NL - Olanda 7
SG - Singapore 7
CH - Svizzera 6
MX - Messico 5
ES - Italia 4
IR - Iran 4
DK - Danimarca 3
GR - Grecia 3
RO - Romania 3
CZ - Repubblica Ceca 2
EU - Europa 2
ID - Indonesia 2
RU - Federazione Russa 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BS - Bahamas 1
CL - Cile 1
CO - Colombia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.814
Salva come PNG Salva come JPEG
Città #
Chandler 540
New York 167
Dakar 164
San Mateo 123
Jacksonville 113
Menlo Park 80
Lawrence 77
Roxbury 77
Vienna 73
Ashburn 63
Hong Kong 50
Rende 49
Shanghai 49
Dearborn 45
Des Moines 44
Brooklyn 38
Ogden 37
Cosenza 34
Ottawa 30
Cambridge 25
Helsinki 23
Ann Arbor 22
Catanzaro 21
Inglewood 21
Redwood City 21
Beijing 19
Wilmington 16
Pune 15
Milan 14
Seattle 14
Brussels 13
Florence 13
Tokyo 13
Vibo Valentia 12
Izmir 11
West Jordan 10
Paris 9
Bari 8
Dublin 8
Naples 8
San Francisco 8
Santa Clara 8
Washington 8
Reggio Calabria 7
Rome 7
Toronto 7
Amantea 6
Crotone 6
Guardavalle 6
Houston 6
Lamezia Terme 6
London 6
Mercato San Severino 6
Norwalk 6
Strasbourg 6
Arezzo 5
Carolei 5
Catania 5
Montauro 5
Boardman 4
Borås 4
Castrolibero 4
Chicago 4
Esslingen am Neckar 4
San Cesario di Lecce 4
Santa Caterina Albanese 4
Suffern 4
Sydney 4
Trecastagni 4
Ahmedabad 3
Andover 3
Athens 3
Bremen 3
Copenhagen 3
Garden City 3
Grafing 3
Ludhiana 3
Melbourne 3
Messina 3
North East 3
Palhoca 3
Palizzi Marina 3
Rosarno 3
San Jose 3
Seelze 3
Seoul 3
São Paulo 3
Taurianova 3
Zapopan 3
Acireale 2
Africo 2
Amsterdam 2
Ardore 2
Aversa 2
Barcelona 2
Bisignano 2
Canberra 2
Castrovillari 2
Cedar Knolls 2
Codroipo 2
Totale 2.410
Salva come PNG Salva come JPEG
Nome #
PAIN ASSESSMENT AND TREATMENT IN DEMENTIA AT THE TIME OF COVID-19 192
Aging brain: In search for better neurotherapeutics 97
Bergamot essential oil attenuates anxiety-like behaviour in rats 95
Nanotechnology-based deliviery system of bergamot essential oil, method of preparation of the system and uses thereof. 94
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats 82
Book of Abstracts – Aging Brain: In Search for Better Neurotherapeutics. 74
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Clinical Evidence and Possible Mechanisms 73
Book of Abstracts – Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation. 71
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 70
Pharmacological basis for the treatment of Behavioural and Psychological Symptoms of Dementia (BPSDs) With Aromatherapy 66
Ageing affects nociception in C57BL/6 mice. 66
Opioids Resistance in Chronic Pain Management 62
Benefits and risks associated with cannabis and cannabis derivatives use 59
Aromatherapy in stroke patients: is it time to begin? 57
Bergamot Rehabilitation AgaINst Agitation In Dementia (BRAINAID): study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 56
Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia 56
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies 55
Spinal expression of autophagic markers following intraplantar formalin injection 55
Book of Abstracts - NEW TRENDS IN PAIN RESEARCH From Basic Research to Clinical Translation 53
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs 52
Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance 50
Innovazione farmacoterapeutica necessaria nella gestione dei behavioral and psychological symptoms nella demenza. 50
Impact of nutraceuticals on glaucoma: A systematic review 48
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy 48
Evidenze farmacoepidemiologiche a favore di un ridotto accesso alla cura del dolore in pazienti trattati con inibitori delle colinesterasi e memantina nel territorio dell’Azienda Sanitaria Provinciale di Cosenza. 48
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 48
Aging Brain: In Search of Better Neurotherapeutics 47
Characterization of alpha2-delta1 expression and response to chronic treatment with gabapentin in a mouse model of neuropathic pain. 46
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 46
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 45
Trattamento dei pazienti affetti da demenza in un real-world setting della regione Calabria: gestione dei sintomi comportamentali e del dolore. 45
Neuropharmacology of the neuropsychiatric symptoms of dementia and role of pain: Essential oil of bergamot as a novel therapeutic approach 44
Behavioral effects of continuously administered bergamot essential oil on mice with partial sciatic nerve ligation 44
Gender differences in pain response to peripheral injury in mice. 43
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy. 43
Exploitation of Aromatherapy in Dementia – impact on pain and Neuropsychiatric symptoms 43
Dementia therapeutics and cognitive rehabilitation 42
The need for better access to pain treatment: learning from drug consumption trends in the USA 41
Characterisation of pain sensitivity in ageing mice 41
Effect of Gabapentin in a Neuropathic Pain Model in Mice Overexpressing Human Wild-Type or Human Mutated Torsin A 41
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 41
Current opportunities for drug repurposing in pain management: is there a role for autophagy modulation? 40
Evidence on the neuroprotective properties of brimonidine in glaucoma 40
Pattern of treatment of behavioral and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a center for cognitive disturbances and dementia 40
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 40
New trends in pain research: From basic research to clinical translation 38
Pattern of triptans use: a retrospective prescription study in Calabria, Italy 38
Pharmacoepidemiology evidence in favour of a reduced access to pain treatment in patients assuming acetylcholinesterase inhibitors and memantine in the provincial health district of Cosenza . 38
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 37
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 37
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 37
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 35
Contribution of histamine to nociceptive behaviors induced by intrathecally administered cholecystokinin-8 35
Behavioral and psychological symptoms of dementia (BPSD): evidence on pharmacoutilization from a large sample in the real-world setting 35
Influence of aging on nociception in C57BL/6 mice. 34
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 33
Characterization of mechanical and thermal nociception in ageing mice. 33
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 32
Role of mGlu-5 and mGlu2/3 receptors in behavioural effects of bergamot essential oil 31
Pain and agitation treatment in severe dementia patients: the need for Italian Mobilization–Observation–Behaviour–Intensity–Dementia (I-MOBID2) Pain Scale translation, adaptation and validation with psychometric testing 31
Neuropsychiatric symptoms of dementia: role of pain and essential oil of bergamot as a novel therapeutic. 31
Indagine farmacoepidemiologica sul trattamento antidolorifico dei pazienti affetti da demenza in Calabria. 31
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 30
Translation of bergamot essential oil in clinical trial for control of behavioral and psychological symptoms of dementia (BPSD) 30
Eptinezumab for the treatment of migraine 30
Exploitation of Thermal Sensitivity and Hyperalgesia in a Mouse Model of Dystonia 30
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 29
Anxiolytic-like/relaxant effects of BEO are useful to manage anxiety and agitation symptoms observed in patients with dementia 28
Evidence from the real-world of limited access to pain treatment in a large sample of patients suffering from dementia. 27
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 27
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 27
CANNABIS UPDATE 2.0 26
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 26
Involvment of metabotropic glutamate receptors in behavioural effects of bergamot essential oil 26
New trends in pharmacological control of neuropsychiatric symptoms of dementia 26
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 24
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 24
Editorial: "Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation" 24
Neuropharmacology of behavioral disorders in dementia. 24
Efficacy of essential oils in pain: a systematic review and meta-analysis of preclinical evidence 23
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-like Behaviour in Female Rats 23
Proposal of combination therapies to treat refractory chronic migraine. 22
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 22
Focus on zavegepant: the first intranasal third-generation gepant 21
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol. 20
Pain assessment for better pharmacological treatment of pain and agitation in severe dementia: I-MOBID2 validation. 20
Validation of an international pain assessment tool to improve pharmacological treatment of pain and agitation in severe dementia. 20
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 20
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 20
Essential oils-induced analgesia and related translation for the management of agitation in dementia 17
Need for a clinical trial investigating efficacy and safety of oral spray nabiximols for pain and agitation treatment in severe dementia patients. 17
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 16
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 16
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 16
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 16
Requirements for translation in clinical trials of aromatherapy: the case of the essential oil of bergamot (BEO) for the management of agitation in severe dementia 15
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 14
Unbiased research is needed for rational translation of essential oils in clinic 13
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 13
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy. 12
Totale 4.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 4 14 0
2019/2020271 13 13 2 14 15 46 14 29 47 11 47 20
2020/2021590 128 80 75 63 29 31 16 52 30 59 2 25
2021/2022988 11 73 29 42 70 50 79 174 34 59 131 236
2022/20231.333 128 144 77 181 114 137 34 214 122 55 76 51
2023/2024794 76 60 61 49 62 228 46 50 129 33 0 0
Totale 4.087